Skip to content

Interscalene Block Versus Supraclavicular Block for Shoulder Surgery

A Randomized Comparison Between Interscalene and Supraclavicular Brachial Plexus Blocks For Arthroscopic Shoulder Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03224884
Enrollment
44
Registered
2017-07-21
Start date
2017-07-24
Completion date
2017-10-25
Last updated
2017-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diaphragmatic Paralysis, Pain, Postoperative, Shoulder Pain, Surgical Procedure, Unspecified

Brief summary

Interscalene brachial plexus block constitutes the analgesic criterion standard for shoulder surgery. However it is associated with a high incidence of hemidiaphragmatic paralysis (HDP) that may not be tolerated by patients with chronic pulmonary disease. This randomized controlled trial will compare ultrasound-guided interscalene block (ISB) and supraclavicular block in patients undergoing arthroscopic shoulder surgery. The main outcome is static pain at 30 minutes after arrival in the post anesthesia care unit (PACU) as measured by a numerical rate scale (NRS) from 0 to 10. Our research hypothesis is that interscalene and supraclavicular blocks will result in equivalent postoperative analgesia at 30 minutes in the PACU. The equivalence margin is set at 2 points

Interventions

PROCEDUREInterscalene block

Ultrasound guided brachial plexus block injecting 20 mL of 0.5% levobupivacaine with 5 micrograms of epinephrine per mL in the interscalene groove, under the prevertebral fascia.

Ultrasound guided brachial plexus injecting 20 mL of 0.5% levobupivacaine with 5 micrograms of epinephrine per mL (3 mL in the corner pocket followed by 17 mL posterolateral to the brachial plexus).

Sponsors

University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing arthroscopic shoulder surgery * American Society of Anesthesiologists classification 1-3 * Body mass index between 20 and 35

Exclusion criteria

* Adults who are unable to give their own consent * Pre-existing neuropathy * Coagulopathy * Obstructive or restrictive pulmonary disease * Renal failure * Hepatic failure * Allergy to local anesthetics * Pregnancy * Prior surgery in the corresponding side of the neck or supraclavicular fossa * Chronic pain syndromes requiring opioid intake at home

Design outcomes

Primary

MeasureTime frameDescription
Static pain at 30 minutes after arrival in the PACU30 minutesEvaluated with a NRS from 0 to 10.

Secondary

MeasureTime frameDescription
Postoperative static pain at 12 hours12 hoursEvaluated with a NRS from 0 to 10.
Postoperative static pain at 24 hours24 hoursEvaluated with a NRS from 0 to 10.
Intraoperative opioid requirementsIntraoperative periodTotal amount of fentanyl required during general anesthesia.
Surgical durationintraoperative periodTime between skin incision and closure.
Static pain at 60 minutes after arrival in the PACU60 minutesEvaluated with a NRS from 0 to 10.
Postoperative static pain at 2 hours2 hoursEvaluated with a NRS from 0 to 10.
Postoperative static pain at 3 hours3 hoursEvaluated with a NRS from 0 to 10.
Incidence of HDP at 30 minutes after interscalene or supraclavicular block30 minutes post injectionUltrasound diagnosed HDP
Postoperative static pain at 6 hours6 hoursEvaluated with a NRS from 0 to 10.
Block performance time1 hour before surgeryTime from skin desinfection until the end of local anesthetic injection.
Sensory and Motor block30 minutes post injectionSensorimotor block assessed every 5 minutes until 30 minutes using a 8-point composite score.
Incidence of complete block30 minutes post injectionPercentage of blocks with a minimal sensorimotor composite score of 6 points out of a maximum of 8 points at 30 minutes post injection.
Procedural pain during blocks1 hour before surgeryEvaluated with a NRS from 0 to 10.
Onset time1 hour before surgeryTime required to reach a minimal sensorimotor composite score of 6 points out of a maximum of 8 points.
Postoperative opioid consumption24 hours after surgeryTotal amount of morphine required during the first 24 hours after surgery.
Patient satisfaction24 hours after surgeryPatient satisfaction measured using a NRS 0 to 10 (0 = unsatisfied; 10 = very satisfied).
Block- and opioid-related side effects1 weekIncidence of side effects.
Incidence of HDP at 30 minutes after arrival to PACU.30 minutes after arrival to PACUUltrasound diagnosed HDP

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026